SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Machaon who wrote (20982)5/17/1998 12:43:00 PM
From: RXGOLF  Read Replies (2) | Respond to of 32384
 
<<I wonder if this problem might have effected LGND's share price over the last year?>>

Robert, my partners and I have discussed this possible patent problem several times in the past. IMO it has affected the amount of money some have been willing to pay for LGND. It would be interesting to know where this stands as we speak. I think it is a point worth making that LGND must have some confidence as work continues at full speed.

Good Luck,
Greg



To: Machaon who wrote (20982)5/17/1998 5:34:00 PM
From: Henry Niman  Read Replies (3) | Respond to of 32384
 
Bob, The Roche patent issue is several years old. I has been discussed many times here and on Yahoo!. LGND has an earlier filing date and the discovered that 9-cis retinoic acid was a natural hormone in a 1992 Cell paper.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News